LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the first quarter ended March 31, 2021 and provided an update on key strategic and operational initiatives. “2021 is off to an encouraging start as we have continued to build on the positive trends seen in the second half of last year and achieved

Full Story →